DXd antibody-drug conjugates

DXd ADC platform · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXd antibody-drug conjugates, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors [Phase 1]